TY - JOUR
AU - K. C. Priest
AU - D. McCarty
AU - T. I. Lovejoy
A1 - 
AB - To mitigate morbidity and mortality of the drug-related overdose crisis, the Veterans Health Administration (VHA) can increase access to treatments that save lives-medications for opioid use disorder (MOUD). Despite an increasing need, MOUD continues to be underutilized due to multifaceted barriers that exist within broader macro- and microenvironments. To promote MOUD utilization, policymakers and healthcare leaders should (1) identify and implement person-centered MOUD delivery systems (e.g., the Medication First Model, community-informed design); (2) recognize and address MOUD delivery gaps (e.g., the Best-Practice in Oral Opioid Agonist Collaborative); (3) broaden the definition of the MOUD delivery system (e.g., access to MOUD in non-clinical settings); and (4) expand MOUD options (e.g., injectable opioid agonist therapy). Increasing access to MOUD is not a singular fix to the overdose-related crisis. It is, however, a possible first step to mitigate harm, and save lives.
AD - School of Medicine, MD/PhD Program, Oregon Health & Science University, Portland, OR, USA. priest@ohsu.edu.; School of Public Health, Oregon Health & Science University-Portland State University, Portland, OR, USA.; School of Public Health, Oregon Health & Science University-Portland State University, Portland, OR, USA.; Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.; Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, OR, USA.
BT - Journal of general internal medicine
C5 - Education & Workforce; Healthcare Disparities; Healthcare Policy; Opioids & Substance Use
CP - Suppl 3
DO - 10.1007/s11606-020-06266-3
IS - Suppl 3
JF - Journal of general internal medicine
LA - eng
M1 - Journal Article
N2 - To mitigate morbidity and mortality of the drug-related overdose crisis, the Veterans Health Administration (VHA) can increase access to treatments that save lives-medications for opioid use disorder (MOUD). Despite an increasing need, MOUD continues to be underutilized due to multifaceted barriers that exist within broader macro- and microenvironments. To promote MOUD utilization, policymakers and healthcare leaders should (1) identify and implement person-centered MOUD delivery systems (e.g., the Medication First Model, community-informed design); (2) recognize and address MOUD delivery gaps (e.g., the Best-Practice in Oral Opioid Agonist Collaborative); (3) broaden the definition of the MOUD delivery system (e.g., access to MOUD in non-clinical settings); and (4) expand MOUD options (e.g., injectable opioid agonist therapy). Increasing access to MOUD is not a singular fix to the overdose-related crisis. It is, however, a possible first step to mitigate harm, and save lives.
PY - 2020
SN - 1525-1497; 0884-8734; 0884-8734
SP - 886
EP - 890
EP - 
T1 - Expanding Access to Medications for Opioid Use Disorder: Program and Policy Approaches from Outside the Veterans Health Administration
T2 - Journal of general internal medicine
TI - Expanding Access to Medications for Opioid Use Disorder: Program and Policy Approaches from Outside the Veterans Health Administration
U1 - Education & Workforce; Healthcare Disparities; Healthcare Policy; Opioids & Substance Use
U2 - 33145685
U3 - 10.1007/s11606-020-06266-3
VL - 35
VO - 1525-1497; 0884-8734; 0884-8734
Y1 - 2020
Y2 - Dec
ER -